Abstract:Photodynamic therapy (PDT) of cancer is a clinically approved, minimally invasive therapeutic approach, combining PDT drug (photosensitizer, PS), molecular oxygen and light to produce cytotoxicity via reactive oxygen species (ROS), which are generated by the light excited PS. Most of the PS molecules fluoresce under excitation with light and fluorescence imaging (FLI) can be employed to evaluate their biodistribution and assess the intratumoral delivery before the therapeutic light application. Light absorption can also be utilized to track a PS by photoacoustic imaging (PAI). However, an excitation of the PS during assessment of its biodistribution through FLI or PAI results in premature photobleaching and causes toxicity. An involvement of a separate fluorescent (luminescent) or photoacoustic imaging probe, which provides imaging contrast in combination with PS without excitation of the latter, can allow for "see-and-treat" approach with FLI/PAI guided PDT. On the other hand, it is well-known that near-infrared (NIR) light is able to penetrate relatively deeper in comparison with visible light, due to reduced absorption and scattering. In addition to the conventional NIR window (NIR-I, ~700-950 nm), other transparency windows for biological tissues have recently been identified at ~1000-1700 nm (NIR-II), benefiting optical bioimaging due to the reduced tissue scattering and autofluorescence. Multiple NIR-II imaging probes are currently introduced both for luminescence and photoacoustic bioimaging, providing the significantly improved signal to noise ratio (SNR), imaging depth and resolution. Their combinations with PS are also being increasingly reported, though no review on this hot topic currently exists. Herein, a state-of-the-art in NIR photoluminescence (including fluorescence) and photoacoustic imaging guided PDT is presented. NIR-I and NIR-II spectral ranges are considered, along with both molecular and nanoparticle formulations for imaging guided PDT. It is expected that this review will provide a solid foundation for future translational studies in the domain of NIR imaging guided photodynamic therapy and drug delivery.

Terahertz Spectroscopy Sheds Light on Real‐Time Exchange Kinetics Occurring through Plasma Membrane during Photodynamic Therapy Treatment

Application of a Dual-Probe Coloading Nanodetection System in the Process Monitoring and Efficacy Assessment of Photodynamic Therapy: An <i>In Vitro</i> Study

Effects of Photodynamic Therapy on Tumor Metabolism and Oxygenation Revealed by Fluorescence and Phosphorescence Lifetime Imaging

Cellular Imaging and Time-Domain FLIM Studies of Meso-Tetraphenylporphine Disulfonate as a Photosensitising Agent in 2D and 3D Models

Correlation of in vitro cell viability and cumulative singlet oxygen luminescence from protoporphyrin IX in mitochondria and plasma membrane

Real-Time in Situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light

AIE Based Theranostic Agent: In-Situ Tracking Mitophagy Prior to Late Apoptosis to Guide the Photodynamic Therapy.

Phototherapy: Targeting‐Triggered Porphysome Nanostructure Disruption for Activatable Photodynamic Therapy (adv. Healthcare Mater. 8/2014)

Unraveling Microviscosity Changes Induced in Cancer Cells by Photodynamic Therapy with Targeted Genetically Encoded Photosensitizer

In vivo Online label-free monitoring of heterogenous oxygen utilization during phototherapy with real-time ultrasound guided photoacoustic imaging

Smart Tumor‐Cell‐Derived Microparticles Provide On‐Demand Photosensitizer Synthesis and Hypoxia Relief for Photodynamic Therapy

Single Cell Imaging of Electrochemiluminescence‐Driven Photodynamic Therapy

Recent Progress in Thermally Activated Delayed Fluorescence Photosensitizers for Photodynamic Therapy

Molecular And Nanoparticulate Agents For Photodynamic Therapy Guided By Near Infrared Imaging

Fluorescence Detection of Protoporphyrin Ix in Living Cells: A Comparative Study on Single- and Two-Photon Excitation

EARLY BIOCHEMICAL RESPONSES TO PHOTODYNAMIC THERAPY MONITORED BY NMR SPECTROSCOPY

Study of cytotoxic effect of photodynamically and sonodynamically activated sensitizers in vitro

X-ray Activated Nanoplatforms for Deep Tissue Photodynamic Therapy

Unveiling the Spatiotemporal and Dose Responses within a Single Live Cancer Cell to Photoswitchable Upconversion Nanoparticle Therapeutics Using Hybrid Hyperspectral Stimulated Raman Scattering and Transient Absorption Microscopy

Derivative UV-VIS Spectrophotometry for Porphyrins Interactions in Photodynamic Therapy

Molecular Engineering of Plasma Membrane and Mitochondria Dual‐Targeted NIR‐II AIE Photosensitizer Evoking Synergetic Pyroptosis and Apoptosis